Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2601-2606

  Kautio, Anna Liisa ^a,b   Haanpää, Maija ^a   Leminen, Arto ^a   Kalso, Eija ^a,c   Kautiainen, Hannu ^d,e   Saarto, Tiina ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Central Finland Central Hospital   (Finland)

^e Orton Hospital   (Finland)

Author keywords

Amitriptyline; Antidepressants; Chemotherapy induced neuropathy; Neoplasms; Neurotoxicity; Prevention

Indexed keywords

AMITRIPTYLINE; PLACEBO; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; VINCA ALKALOID;

ADULT; AGED; ANOREXIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL EXAMINATION; CLINICAL TRIAL; COLORECTAL CANCER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MOTOR NEUROPATHY; NAUSEA; NEUROPATHY; NIGHTMARE; OVARY CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; SIDE EFFECT; SWEATING; SYMPTOMATOLOGY; TREMOR; UTERUS CANCER; VISUAL DISORDER; XEROSTOMIA;

ADULT; AGED; AMITRIPTYLINE; ANTINEOPLASTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PERIPHERAL NERVOUS SYSTEM DISEASES; PLACEBOS;

EID: 69249165807     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Quasthoff S and Hartung HP: Chemotherapy-induced peripheral neuropathy. J Neurol 249: 9-17, 2002.
2. Ocean AJ and Vahdat LT: Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 12: 619-625, 2004. (Pubitemid 39280311)
3. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, Cormier Y, Goss G, Inculet R, Vallieres E, Fry W, Bethune D, Ayoub J, Ding K, Seymour L, Graham B, Tsao MS, Gandara D, Kesler K, Demmy T and Shepherd F: Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 352: 2589-2597, 2005. (Pubitemid 41007845)
4. Albers J, Chaudhry V, Cavaletti G and Donehower R: Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev 24(1): CD005228, 2007. (Pubitemid 351820483)
5. Walker M and Ni O: Neuroprotection during chemotherapy. A systematic review. Am J Clin Oncol 30: 82-92, 2007.
6. Wolf S, Barton D, Kottschade L, Grothey A and Loprinzi C: Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. Eur J Cancer 44: 1507-1515, 2008.
7. Saarto T and Wiffen PJ: Antidepressants for neuropathic pain. Cochrane Database Syst Rev 20(3): CD005454, 2005.
8. Bowsher D: The effect of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 13: 327-331, 1997. (Pubitemid 27280025)
9. Postma TJ and Heimans JJ: Grading chemotherapy-induced peripheral neuropathy. Ann Oncol 11: 509-513, 2000.
10. Ford ME. Havstad SL and Kart CS: Assessing the reliability of the EORTC QLQ-C30 in a sample of older African-American and Caucasian adults. Quality of Life Res 10(6): 533-541, 2001.
11. Mitchell PL, Goldstein D, Michael M, Beale P, Friedlander M, Zalcberg J, White S, Thomson JA and Clarke S: Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. Clin Colorectal Cancer 6: 146-151, 2006. (Pubitemid 44445750)
12. von Delius S, Eckel F, Wagenpfeil S , Mayr M, Stock K, Kullmann F, Obermeier F, Erdmann J, Schmelz R, Quasthoff S, Adelsberger H, Bredenkamp R, Schmid RM and Lersch C: Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. Invest New Drugs 25: 173-180, 2007. (Pubitemid 46020877)
13. Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A 3rd, von Hoff D and Schuchter LM: American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27(1): 127-45, 2009.
14. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P and EFNS Task Force: EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13: 1153-1169, 2006. (Pubitemid 44581463)
15. Kautio A, Haanpää M, Saarto T and Kalso E: Amitriptylin in the treatment of chemotherapy incuded neuropathic symptoms. J Pain Symptom Manage 35: 31-39, 2008. (Pubitemid 350299098)
16. Hammack JE, Michalak JC, Loprinzi CL, Sloan JA, Novotny PJ, Soori GS, Tirona MT, Row-land KM Jr, Stella PJ and Johnson JA: Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 98: 195-203, 2002.
17. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA and Wong GY; North Central Cancer Treatment Group: Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy. Cancer 110: 21110-22118, 2007.
18. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M and Loprinzi CL: Efficay of lamotrigine in the management of chemotherapy-induced peripheral neuropathy. Cancer 112: 2802-2808, 2008.
19. Kieburtz K, Simpson D, Yiannoutsos C Max MB, Hall CD, Ellis RJ, Marra CM, McKendall R, Singer E, Dal Pan GJ, Clifford DB, Tucker T and Cohen B: A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology 51: 1682-1688, 1998.
20. Shlay JC, Chaloner K, Max MB, Flaws B, Reichelderfer P, Wentworth D, Hillman S, Brizz B and Cohn DL: Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 280: 1590-1595, 1998.